Healthcare Trust, Inc. Files 8-K with Financials

TL;DR

HTI filed an 8-K on 3/26/24 with financials and Reg FD disclosure.

AI Summary

Healthcare Trust, Inc. filed an 8-K on March 26, 2024, reporting on financial statements and exhibits. The filing also includes a Regulation FD Disclosure. The company was formerly known as American Realty Capital Healthcare Trust II, Inc. until October 25, 2012.

Why It Matters

This filing provides updated financial information and disclosures for Healthcare Trust, Inc., which is important for investors to assess the company's current financial health and regulatory compliance.

Risk Assessment

Risk Level: low — This is a routine filing of financial statements and disclosures, not indicating any immediate financial distress or significant new risks.

Key Players & Entities

• Healthcare Trust, Inc. (company) — Registrant
• American Realty Capital Healthcare Trust II, Inc. (company) — Former company name
• March 26, 2024 (date) — Filing date
• October 25, 2012 (date) — Date of name change

FAQ

Key Financial Figures

• $0.01 — e Redeemable Perpetual Preferred Stock, $0.01 par value per share HTIA The Nasdaq G
• $0.4609375 — uncing the declaration of a dividend of $0.4609375 per share payable on April 15, 2024 to
• $0.4453125 — ounced the declaration of a dividend of $0.4453125 per share payable on April 15, 2024 to

Filing Documents

• tm249708d1_8k.htm (8-K) — 32KB
• tm249708d1_ex99-1.htm (EX-99.1) — 9KB
• image_001.jpg (GRAPHIC) — 4KB
• 0001104659-24-039032.txt ( ) — 262KB
• hti-20240326.xsd (EX-101.SCH) — 4KB
• hti-20240326_def.xml (EX-101.DEF) — 26KB
• hti-20240326_lab.xml (EX-101.LAB) — 36KB
• hti-20240326_pre.xml (EX-101.PRE) — 25KB
• tm249708d1_8k_htm.xml (XML) — 6KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Preferred Stock Dividends On March 26, 2024, Healthcare Trust, Inc. (the "Company") issued a press release announcing the declaration of a dividend of $0.4609375 per share payable on April 15, 2024 to holders of record of shares of the Company's 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock at the close of business on April 5, 2024. In addition, the Company announced the declaration of a dividend of $0.4453125 per share payable on April 15, 2024 to holders of record of shares of the Company's 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock at the close of business on April 5, 2024. A copy of the press release is attached as Exhibit 99.1, and is hereby incorporated by reference into this Item 7.01. The information contained in this Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except to the extent expressly stated in such filing .

Forward-Looking Statements

Forward-Looking Statements The statements in this Current Report on Form 8-K that are not historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words "anticipates," "believes," "expects," "estimates," "projects," "plans," "intends," "may," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company's control, which could cause actual results to differ materially from the results contemplated by the forward-looking actions taken to contain or treat COVID-19, (ii) the geopolitical instability due to the ongoing military conflict between Russia and Ukraine and Israel and Hamas, including related sanctions and other penalties imposed by the U.S. and European Union, and the related impact on the Company, the Company's tenants, the Company's operators and the global economy and financial markets, and (iii) inflationary conditions and higher interest rate environments, as well as those risks and uncertainties set forth in the Risk Factors section of the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed on March 15, 2024, as amended by the Form 10-K/A filed on March 22, 2024, and all other filings with the Securities and Exchange Commission after that date, as such risks, uncertainties and other important factors may be updated from time to time in the Company's subsequent filings with the Securities and Exchange Commission. Further, forward-looki

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated March 26, 2024 . 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHCARE TRUST, INC. Date: March 26, 2024 By: /s/ Scott M. Lappetito Scott M. Lappetito Chief Financial Officer, Secretary and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR